Quantifying heterogeneity in individual participant data meta-analysis with binary outcomes

BackgroundIn meta-analyses (MA), effect estimates that are pooled together will often be heterogeneous. Determining how substantial heterogeneity is is an important aspect of MA.MethodWe consider how best to quantify heterogeneity in the context of individual participant data meta-analysis (IPD-MA) of binary data. Both two- and one-stage approaches are evaluated via simulation study. We consider conventional I2 and R2 statistics estimated via a two-stage approach and R2 estimated via a one-stage approach. We propose a simulation-based intraclass correlation coefficient (ICC) adapted from Goldstein et al. to estimate the I2, from the one-stage approach.ResultsResults show that when there is no effect modification, the estimated I2 from the two-stage model is underestimated, while in the one-stage model, it is overestimated. In the presence of effect modification, the estimated I2 from the one-stage model has better performance than that from the two-stage model when the prevalence of the outcome is high. The I2 from the two-stage model is less sensitive to the strength of effect modification when the number of studies is large and prevalence is low.ConclusionsThe simulation-based I2 based on a one-stage approach has better performance than the conventional I2 based on a two-stage approach when there is strong effect modification with high prevalence.

[1]  Ralf Bender,et al.  Methods to estimate the between‐study variance and its uncertainty in meta‐analysis† , 2015, Research synthesis methods.

[2]  N. Dendukuri,et al.  Statistics for quantifying heterogeneity in univariate and bivariate meta‐analyses of binary data: The case of meta‐analyses of diagnostic accuracy , 2014, Statistics in medicine.

[3]  N. Breslow,et al.  Bias Correction in Generalized Linear Mixed Models with Multiple Components of Dispersion , 1996 .

[4]  D. Firth,et al.  Estimating Intraclass Correlation for Binary Data , 1999, Biometrics.

[5]  A Whitehead,et al.  A general parametric approach to the meta-analysis of randomized clinical trials. , 1991, Statistics in medicine.

[6]  Gary H Lyman,et al.  The strengths and limitations of meta-analyses based on aggregate data , 2005, BMC Medical Research Methodology.

[7]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[8]  W. Wong,et al.  Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. , 2012, Contemporary clinical trials.

[9]  P. Diggle Analysis of Longitudinal Data , 1995 .

[10]  Stephen J. Gentles,et al.  Factors explaining the heterogeneity of effects of patient decision aids on knowledge of outcome probabilities: a systematic review sub-analysis , 2013, Systematic Reviews.

[11]  Paul Landais,et al.  Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. , 2004, Journal of clinical epidemiology.

[12]  Richard D Riley,et al.  Meta‐analysis of continuous outcomes combining individual patient data and aggregate data , 2008, Statistics in medicine.

[13]  I. White,et al.  Quantifying the impact of between-study heterogeneity in multivariate meta-analyses , 2012, Statistics in medicine.

[14]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[15]  C. Pipper,et al.  [''R"--project for statistical computing]. , 2008, Ugeskrift for laeger.

[16]  H. Goldstein,et al.  Variance partitioning in multilevel logistic models that exhibit overdispersion , 2005 .

[17]  Lisa N Yelland,et al.  Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care , 2011, Clinical trials.

[18]  Dan Jackson,et al.  The exact distribution of Cochran's heterogeneity statistic in one‐way random effects meta‐analysis , 2008, Statistics in medicine.

[19]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[20]  Gerta Rücker,et al.  Bmc Medical Research Methodology Open Access Undue Reliance on I 2 in Assessing Heterogeneity May Mislead , 2022 .

[21]  S. Cousens,et al.  Measures of between‐cluster variability in cluster randomized trials with binary outcomes , 2009, Statistics in medicine.

[22]  P C Lambert,et al.  A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. , 2002, Journal of clinical epidemiology.

[23]  John Uebersax,et al.  Statistical Modeling of Expert Ratings on Medical Treatment Appropriateness , 1993 .

[24]  A Whitehead,et al.  Meta‐analysis of continuous outcome data from individual patients , 2001, Statistics in medicine.

[25]  Woncheol Jang,et al.  A Numerical Study of PQL Estimation Biases in Generalized Linear Mixed Models Under Heterogeneity of Random Effects , 2009, Commun. Stat. Simul. Comput..

[26]  Harvey Goldstein,et al.  Partitioning variation in multilevel models , 2002 .

[27]  R. Riley Commentary: like it and lump it? Meta-analysis using individual participant data. , 2010, International journal of epidemiology.

[28]  Jack Bowden,et al.  How does the DerSimonian and Laird procedure for random effects meta-analysis compare with its more efficient but harder to compute counterparts? , 2010 .

[29]  Andrea Benedetti,et al.  Systematic review of methods for individual patient data meta- analysis with binary outcomes , 2014, BMC Medical Research Methodology.

[30]  Hendrik Koffijberg,et al.  Individual Participant Data Meta-Analysis for a Binary Outcome: One-Stage or Two-Stage? , 2013, PloS one.

[31]  N. Breslow,et al.  Approximate inference in generalized linear mixed models , 1993 .